NCT07228247
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07228247
Title A Phase I/IIa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchmed
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
SCRI HealthONE NOT_YET_RECRUITING Denver Colorado 80218 United States Details
BRCR Global NOT_YET_RECRUITING Plantation Florida 33322 United States Details
Memorial Sloan Kettering Cancer Center NOT_YET_RECRUITING New York New York 10065 United States Details
Cleveland Clinic Taussig Cancer Center NOT_YET_RECRUITING Cleveland Ohio 44195 United States Details
Vanderbilt University Medical Center NOT_YET_RECRUITING Nashville Tennessee 37232 United States Details
Peking University First Hospital NOT_YET_RECRUITING Beijing China Details
Hunan Cancer Hospital NOT_YET_RECRUITING Changsha China Details
Fujian Cancer Hospital NOT_YET_RECRUITING Fujian China Details
Sun Yat-sen University Cancer Center RECRUITING Guangzhou China Details
The First Affiliated Hospital of Anhui Medical University RECRUITING Hefei China Details
Henan Cancer Hospital NOT_YET_RECRUITING Zhengzhou China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field